Circulating Epigenetics in Pancreatic Surgery
- Conditions
- Pancreatic Neoplasms
- Registration Number
- NCT04947696
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The overall objective of the study is to assess DNA-methylation changes in circulating blood cells and cell free DNA in plasma from patients undergoing the Whipples procedure for pancreatic caner
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Patients with pancreatic cancer scheduled for the Whipples procedure
Exclusion Criteria
- Under 18 years of age
- Pregnancy
- Unable to provide informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in DNA-methylation patterns from the pre to postoperative setting Up to 30 days postoperatively
- Secondary Outcome Measures
Name Time Method Occurence of a postoperative complication 30 days postoperatively Relapse of pancreatic cancer 2 years from time of operation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does DNA methylation profiling in NCT04947696 correlate with survival outcomes in pancreatic ductal adenocarcinoma patients post-Whipple procedure?
What molecular pathways are implicated by circulating cell-free DNA methylation changes in pancreatic cancer as studied in NCT04947696?
Can epigenetic biomarkers from NCT04947696 improve patient stratification for neoadjuvant therapy in resectable pancreatic tumors?
What adverse events are associated with blood sampling in epigenetic studies of pancreatic cancer patients undergoing surgical resection?
How does integrative deep learning analysis of DNA methylation in NCT04947696 compare to liquid biopsy approaches for PDAC monitoring?
Trial Locations
- Locations (1)
Rigshospitalet
🇩🇰Copenhagen, Denmark
Rigshospitalet🇩🇰Copenhagen, DenmarkMartin Sillesen, MD, PhDPrincipal Investigator